|
Normal control group
|
110 ± 4.01
|
118.25 ± 8.99
|
108.75 ± 4.57
|
111.5 ± 4.20
|
|
Diabetic control group
|
112.5 ± 9.14
|
121.75 ± 11.35
|
150.75 ± 5.25*
|
151.25 ± 5.12*
|
|
Diabetic group treated with bromocriptine
|
115 ± 9.12
|
102.75 ± 6.8
|
109 ± 10.23#
|
121.75 ± 15.26#
|
|
Diabetic group treated with cabergoline
|
103.75 ± 7.0
|
105.5 ± 9.14
|
123 ± 7.87#
|
107.75 ± 107.75#
|
|
Diabetic group treated with sarpogrelate
|
118.75 ± 10.87
|
114.75 ± 8.53
|
137.75 ± 8.53
|
139 ± 18.56
|
|
Diabetic group treated with bromocriptine + sarpogrelate
|
104.5 ± 7.59
|
104.75 ± 4.99
|
106.25 ± 11.08#
|
118 ± 13.03#
|
|
Diabetic group treated with cabergoline + sarpogrelate
|
109.25 ± 11.58
|
105 ± 9.05
|
106 ± 18.3#
|
104.25 ± 5.5#
|
